Non-inferiority design for trials in multiple sclerosis

Lancet Neurol. 2024 Oct;23(10):970. doi: 10.1016/S1474-4422(24)00336-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials as Topic / methods
  • Equivalence Trials as Topic
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Multiple Sclerosis* / therapy
  • Research Design*